Evidence map›Paper›PMID 34128836›Full record

Observational studyJCI insight2021

High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria.

Lisa J Ioannidis, Halina M Pietrzak, Ann Ly, Retno As Utami, Emily M Eriksson, Stephanie I Studniberg, Waruni Abeysekera, Connie Sn Li-Wai-Suen, Dylan Sheerin, Julie Healer and 14 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 4 countries.

Lisa J IoannidisWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Halina M PietrzakWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Ann LyWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Retno As UtamiWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Emily M ErikssonWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Stephanie I StudnibergWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Waruni AbeysekeraWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Connie Sn Li-Wai-SuenWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Dylan SheerinWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Julie HealerWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Agatha M PuspitasariEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Dwi ApriyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Farah N CoutrierEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Jeanne R PoespoprodjoPapuan Health and Community Development Foundation, Papua, Indonesia.
Enny KenangalemPapuan Health and Community Development Foundation, Papua, Indonesia.
Benediktus AndriesPapuan Health and Community Development Foundation, Papua, Indonesia.
Pak PrayogaPapuan Health and Community Development Foundation, Papua, Indonesia.
Novita SariyantiPapuan Health and Community Development Foundation, Papua, Indonesia.
Gordon K SmythWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Leily TriantyEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Alan F CowmanWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Ric N PriceGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
Rintis NoviyantiEijkman Institute for Molecular Biology, Jakarta, Indonesia.
Diana S HansenWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
The University of Melbourne · AUEijkman Institute for Molecular Biology · IDState University of Papua · IDMahidol University · TH

Funding

Wellcome Trust 200909/Z/16/Z
6 · The paper itself

Abstract

IFN-γ-driven responses to malaria have been shown to modulate the development and function of T follicular helper (TFH) cells and memory B cells (MBCs), with conflicting evidence of their involvement in the induction of antibody responses required to achieve clinical immunity and their association with disease outcomes. Using high-dimensional single-cell mass cytometry, we identified distinct populations of TH1-polarized CD4+ T cells and MBCs expressing the TH1-defining transcription factor T-bet, associated with either increased or reduced risk of Plasmodium vivax (P. vivax) malaria, demonstrating that inflammatory responses to malaria are not universally detrimental for infection. Furthermore, we found that, whereas class-switched but not IgM+ MBCs were associated with a reduced risk of symptomatic malaria, populations of TH1 cells with a stem central memory phenotype, TH17 cells, and T regulatory cells were associated with protection from asymptomatic infection, suggesting that activation of cell-mediated immunity might also be required to control persistent P. vivax infection with low parasite burden.

Indexed as

AntimalarialsAsymptomatic InfectionsCD4-Positive T-LymphocytesCross-Sectional StudiesHealthy VolunteersHumansImmunity, CellularImmunophenotypingIndonesiaMalaria, VivaxMemory B CellsPersistent InfectionPlasmodium vivaxAntimalarialsAdaptive immunityImmunologyInfectious diseaseMalaria

Identifiers

PMID34128836
PMCPMC8410020
OpenAlexW3166211892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.